Literature DB >> 24882878

Disease Management Project Breast Cancer in Hesse - 5-Year Survival Data: Successful Model of Intersectoral Communication for Quality Assurance.

C Jackisch1, A Funk2, K König3, D Lubbe4, B Misselwitz5, U Wagner6.   

Abstract

Introduction: The Disease Management Project Breast Cancer (DMP Breast Cancer) was first launched in Hesse in 2004. The project is supported by the health insurance companies in Hesse and the Professional Association of Gynaecologists in Hesse. The aim is to offer structured treatment programmes to all women diagnosed with breast cancer in Hesse by creating intersectoral cooperations between coordinating clinics, associated hospitals and gynaecologists in private practice who registered in the DMP programme. Method: Between 1 January 2005 and 30 June 2011, 13 973 women were enrolled in the DMP programme.
Results: After data cleansing, survival rates were calculated for a total of 11 214 women. The 5-year overall survival (OS) rate was 86.3 %; survival rates according to tumour stage on presentation were 92.2 % (pT1) and 82.3 % (pT2), respectively. The impact of steroid hormone receptor status on survival (87.8 % for receptor-positive cancers vs. 78.9 % for receptor-negative cancers) and of age at first diagnosis on survival (≤ 35 years = 91 %) were calculated.
Conclusion: The project showed that intersectoral cooperation led to significant improvements in the quality of treatment over time, as measured by quality indicators and outcomes after treatment.

Entities:  

Keywords:  breast cancer; disease management programme; network; quality assurance; survival

Year:  2014        PMID: 24882878      PMCID: PMC4024614          DOI: 10.1055/s-0034-1368169

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN: 0016-5751            Impact factor:   2.915


  5 in total

Review 1.  Early breast cancer.

Authors:  John R Benson; Ismail Jatoi; Martin Keisch; Francisco J Esteva; Andreas Makris; V Craig Jordan
Journal:  Lancet       Date:  2009-04-25       Impact factor: 79.321

2.  [Cancer survival analysis in Germany--heading towards representative and comparable findings].

Authors:  A Nennecke; H Brenner; A Eberle; K Geiss; B Holleczek; J Kieschke; K Kraywinkel
Journal:  Gesundheitswesen       Date:  2010-01-04

3.  Adherence to Treatment Guidelines in Breast Cancer Care - a Retrospective Analysis of the 'Organgruppe Mamma der Arbeitsgemeinschaft Gynaekologische Onkologie'

Authors:  Christian Jackisch; Michael Untch; Dimitrios Chatsiproios; Christiane Lamparter; Friedrich Overkamp; Werner Lichtenegger; Wolfgang Rönsberg; Christoph Thomssen; Gunter von Minckwitz; Ute-Susann Albert
Journal:  Breast Care (Basel)       Date:  2008-04-25       Impact factor: 2.860

Review 4.  Quality of breast cancer care: what do we know?

Authors:  Jennifer L Malin; Mark A Schuster; Katherine A Kahn; Robert H Brook
Journal:  J Clin Oncol       Date:  2002-11-01       Impact factor: 44.544

5.  Hospital volume differences and five-year survival from breast cancer.

Authors:  P J Roohan; N A Bickell; M S Baptiste; G D Therriault; E P Ferrara; A L Siu
Journal:  Am J Public Health       Date:  1998-03       Impact factor: 9.308

  5 in total
  2 in total

1.  Should Breast Cancer Surgery Be Done in an Outpatient Setting?: Health Economics From the Perspective of Service Providers.

Authors:  Margaret Formago; Michael G Schrauder; Claudia Rauh; Carolin C Hack; Sebastian M Jud; Thomas Hildebrandt; Rüdiger Schulz-Wendtland; S Frentz; S Graubert; Matthias W Beckmann; Michael P Lux
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-08-24       Impact factor: 2.915

2.  The Treatment of Primary Breast Cancer in Older Women With Adjuvant Therapy: A Retrospective Analysis of Data From Over 3000 Patients From the PATH Biobank, With Two-Year Follow-up.

Authors:  Elke Peters; Tobias Anzeneder; Christian Jackisch; Thomas Dimpfl; Georg Kunz; Alexander Katalinic; Annika Waldmann
Journal:  Dtsch Arztebl Int       Date:  2015-08-31       Impact factor: 5.594

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.